Series A - Neuraptive Therapeutics

Series A - Neuraptive Therapeutics

Investment Firm

Overview

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

Announced Date

Dec 19, 2018

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

New Rhein

New Rhein

New Rhein is a early_stage_venture and venture firm.

Participant Investors

1

Investor Name
Participant InvestorNew Rhein

Round Details and Background

Neuraptive Therapeutics raised $11500000 on 2018-12-19 in Series A

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 19, 2018
Series A - Neuraptive Therapeutics
1-11.5M
Oct 25, 2022
Venture Round - Neuraptive Therapeutics
1-7.5M
Sep 06, 2017
Seed Round - Neuraptive Therapeutics
2-1.0M

Recent Activity

There is no recent news or activity for this profile.